FJX1 as a candidate diagnostic and prognostic serum biomarker for colorectal cancer.
Lei LiuYecai HuangYan LiQiong WangYaying HaoLüye LiuXue YaoXiuju YaoYi WeiXiaobin SunYuanbiao GuoPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2022)
Our findings provided a novel strategy to identify diagnostic biomarkers based on public datasets, and suggested that FJX1 was a candidate diagnostic and prognostic biomarker in CRC patients.